Related Experiment Video

Updated: Sep 26, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Induction of "antigen silencing" in melanomas by oncostatin M: down-modulation of melanocyte antigen expression

Paul J Durda1, Ian S Dunn, Lenora Boyle Rose

  • 1Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA. pdurda@partners.org

Molecular Cancer Research : MCR
|April 15, 2003
PubMed

Insights

Melanoma cells secrete factors like oncostatin M (OSM) that reduce antigen expression. Other unknown factors also down-regulate antigens via distinct pathways, impacting cancer vaccine effectiveness.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Antigen expression in melanoma is crucial for immunotherapy.
  • Melanoma cells can down-regulate antigen expression, potentially evading immune responses.

Purpose of the Study:

  • To identify and characterize factors secreted by melanoma cells that down-regulate antigen expression.
  • To investigate the signaling pathways involved in antigen silencing.
  • To understand the implications for antitumor vaccine immunotherapies.

Main Methods:

  • Purification and characterization of secreted proteins from melanoma cell lines.
  • Analysis of oncostatin M (OSM) and its role in antigen modulation.
  • Investigation of signaling pathways mediated by gp130 receptor.
  • Identification of additional, uncharacterized down-regulatory factors.

Main Results:

  • Oncostatin M (OSM) was identified as a key cytokine that down-regulates melanocyte lineage antigens (Melan-A/MART-1, gp100, tyrosinase, TRP1, TRP2, MITF-M) via the gp130 receptor.
  • Some melanoma cell lines produce distinct, uncharacterized factors that also suppress antigen expression.
  • These additional factors utilize signaling pathways independent of OSM.

Conclusions:

  • Multiple regulatory pathways and molecules contribute to antigen silencing in melanoma.
  • Tumor cell differentiation state may influence these regulatory mechanisms.
  • Understanding these antigen-silencing processes is critical for improving the efficacy of antitumor vaccine immunotherapies.

More Related Videos

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...